June 11, 2025, Montréal, Canada – Vantage BioTrials is proud to announce that it has been named a finalist for the esteemed 2025 Partnership Award, a prestigious award recognizing outstanding collaborative projects within Quebec’s innovation ecosystem. This accolade celebrates the successful partnership between Vantage BioTrials, Groupe Sorintellis, and the Centre de Recherche Informatique de Montréal (CRIM), underscoring a shared commitment to advancing clinical research through innovation and excellence.

The Partnership Award finalist status highlights the strength and impact of this strategic collaboration, which combines Vantage BioTrials’ expertise in clinical trial management with Groupe Sorintellis and CRIM’s cutting-edge technological capabilities. Together, they have developed innovative solutions that enhance the quality, efficiency, and risk management of clinical trials, ultimately accelerating the delivery of life-saving therapies to patients.

At the core of this partnership lies Vantage BioTrials’ commitment to Quality by Design (QbD) and Risk-Based Management (RBM) principles. By integrating these methodologies, the team ensures that clinical trials are meticulously planned, monitored, and optimized from inception to completion, delivering robust data integrity and regulatory compliance while reducing costs and timelines.

“We are truly honored to be recognized among such talented and visionary partners,” said Vatche Bartekian, President of Vantage BioTrials. “This nomination reflects not only the strength of our partnership but also our dedication to driving innovation in clinical research, supporting our clients’ goals, and ultimately improving patient outcomes.”

As a finalist for the Partnership Award, Vantage BioTrials continues to demonstrate leadership within Quebec’s vibrant life sciences and technology sectors. The company looks forward to continuing its collaboration with Groupe Sorintellis and CRIM, contributing to a stronger, more innovative clinical research environment.

About Vantage BioTrials Inc.

Vantage BioTrials is a Contract Research Organization that uses innovative clinical trial management strategies for the life science industry with a focus on patient safety & advancing new therapies to market. We offer pharmaceutical, biotech & medical device companies a complete and integrated set of full service clinical trial management solutions at a competitive value.

For more information about Vantage BioTrials’ services and capabilities, please visit www.vantagebiotrials.com.